Literature DB >> 26970315

Heavy menstrual bleeding on Rivaroxaban - Comparison with Apixaban.

Bethan Myers1,2, Amy Webster1.   

Abstract

Entities:  

Keywords:  anticoagulation; apixaban; direct oral anticoagulants; menorrhagia; rivaroxaban

Mesh：

Substances：

Year:  2016        PMID： 26970315     DOI： 10.1111/bjh.14003

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  14 in total

Review 1.  Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?

Authors:  Jenneke Leentjens; Mike Peters; Anne C Esselink; Yvo Smulders; Cornelis Kramers
Journal:  Br J Clin Pharmacol       Date:  2017-07-09       Impact factor: 4.335

Review 2.  Management of heavy menstrual bleeding on anticoagulation.

Authors:  Bethany Samuelson Bannow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 3.  Reversal of direct oral anticoagulants: a practical approach.

Authors:  Andrew W Shih; Mark A Crowther
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

4.  Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai; Richard F MacLehose; Faye L Norby; Rob F Walker; Nicholas S Roetker; Terrence J Adam; Alvaro Alonso
Journal:  Br J Haematol       Date:  2019-03-28       Impact factor: 6.998

Review 5.  Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation.

Authors:  Faye L Norby; Alvaro Alonso
Journal:  J Comp Eff Res       Date:  2017-07-24       Impact factor: 1.744

6.  Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirin.

Authors:  Kochawan Boonyawat; Anthonie W A Lensing; Martin H Prins; Jan Beyer-Westendorf; Paolo Prandoni; Ida Martinelli; Saskia Middeldorp; Akos F Pap; Jeffrey I Weitz; Mark Crowther
Journal:  Res Pract Thromb Haemost       Date:  2021-02-17

7.  Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.

Authors:  Ljj Scheres; Mpa Brekelmans; W Ageno; C Ay; H R Büller; S Eichinger; B A Hutten; F A Klok; S Middeldorp; K Schreiber; K Stach; M Blondon; A Delluc
Journal:  BJOG       Date:  2018-07-20       Impact factor: 6.531

8.  Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia.

Authors:  C L Shovlin; C M Millar; F Droege; A Kjeldsen; G Manfredi; P Suppressa; S Ugolini; N Coote; A D Fialla; U Geisthoff; G M Lenato; H J Mager; F Pagella; M C Post; C Sabbà; U Sure; P M Torring; S Dupuis-Girod; E Buscarini
Journal:  Orphanet J Rare Dis       Date:  2019-08-28       Impact factor: 4.123

Review 9.  Reversal agents for non-vitamin K antagonist oral anticoagulants.

Authors:  Jerrold H Levy; James Douketis; Jeffrey I Weitz
Journal:  Nat Rev Cardiol       Date:  2018-01-18       Impact factor: 32.419

10.  Venous Thromboembolism: A Survey of Oral Anticoagulant Preferences in the Treatment of Challenging Patient Populations.

Authors:  Genevieve Claire Moyer; Bethany Samuelson Bannow; Courtney Thornburg; Rachel Rosovsky; Tzu-Fei Wang; Scott Woller; Dianne Thornhill; Lisa Baumann Kreuziger
Journal:  Clin Appl Thromb Hemost       Date:  2018-10-02       Impact factor: 2.389
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.